PE20070073A1 - Compuestos heterociclicos como inhibidores de proteasas - Google Patents
Compuestos heterociclicos como inhibidores de proteasasInfo
- Publication number
- PE20070073A1 PE20070073A1 PE2006000663A PE2006000663A PE20070073A1 PE 20070073 A1 PE20070073 A1 PE 20070073A1 PE 2006000663 A PE2006000663 A PE 2006000663A PE 2006000663 A PE2006000663 A PE 2006000663A PE 20070073 A1 PE20070073 A1 PE 20070073A1
- Authority
- PE
- Peru
- Prior art keywords
- protease inhibitors
- heterocyclic compounds
- alkyl
- diseases
- compounds
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 101150009274 nhr-1 gene Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
REFERIDA A UN COMPUESTO DE FORMULA I, DONDE X ES C(R3R4); Y ES N(R5); Z ES C(=N-R5'); R1 Y R2 SON H, ALQUILO, ALQUENILO, CICLOALQUILO, ENTRE OTROS; R5 Y R5' SON H, OH, NHR1, -O-ALQUILO, ARILO, ENTRE OTROS; R3 Y R4 SON H, ALQUILO, ARILALQUILO, HETEROARILALQUILO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE ASPARTIL PROTEASAS Y SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES, ENFERMEDADES COGNITIVAS, ENFERMEDADES NEURODEGENERATIVAS, ENTRE OTRAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69054305P | 2005-06-14 | 2005-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070073A1 true PE20070073A1 (es) | 2007-03-08 |
Family
ID=37571011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000663A PE20070073A1 (es) | 2005-06-14 | 2006-06-13 | Compuestos heterociclicos como inhibidores de proteasas |
Country Status (10)
Country | Link |
---|---|
US (1) | US20080113957A1 (es) |
EP (1) | EP1896406A2 (es) |
JP (1) | JP2008543846A (es) |
CN (1) | CN101193859A (es) |
AR (1) | AR054618A1 (es) |
CA (1) | CA2610617A1 (es) |
MX (1) | MX2007016186A (es) |
PE (1) | PE20070073A1 (es) |
TW (1) | TW200716541A (es) |
WO (1) | WO2006138230A2 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
JP2008543840A (ja) | 2005-06-14 | 2008-12-04 | シェーリング コーポレイション | アスパルチルプロテアーゼインヒビター |
CA2609582A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
EP2644600B1 (en) | 2006-06-12 | 2017-01-11 | Merck Sharp & Dohme Corp. | Heterocyclic aspartyl protease inhibitors |
TW200815349A (en) | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
MX2009006228A (es) | 2006-12-12 | 2009-06-22 | Schering Corp | Inhibidores de aspartil proteasa. |
CA2698341A1 (en) | 2007-09-06 | 2009-03-12 | Schering Corporation | Gamma secretase modulators |
US8487099B2 (en) | 2007-11-05 | 2013-07-16 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
US8426595B2 (en) | 2007-12-11 | 2013-04-23 | Xianhai Huang | Gamma secretase modulators |
PE20110805A1 (es) | 2008-09-11 | 2011-11-09 | Amgen Inc | Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso |
RU2011123862A (ru) | 2008-11-13 | 2012-12-20 | Шеринг Корпорейшн | Модуляторы гамма-секретазы |
TW201020244A (en) | 2008-11-14 | 2010-06-01 | Astrazeneca Ab | New compounds |
JP2012513399A (ja) | 2008-12-22 | 2012-06-14 | シェーリング コーポレイション | γ−セクレターゼ調節剤 |
AR074702A1 (es) | 2008-12-22 | 2011-02-02 | Schering Corp | Moduladores de gamma secretasa y composiciones farmaceuticas que los contienen |
WO2010147973A1 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | Gamma secretase modulators |
EP2443121A2 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
EP2443119A1 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | Gamma secretase modulators |
EP2281824A1 (en) | 2009-08-07 | 2011-02-09 | Noscira, S.A. | Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
WO2011044185A2 (en) | 2009-10-08 | 2011-04-14 | Schering Corporation | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
US8563543B2 (en) | 2009-10-08 | 2013-10-22 | Merck Sharp & Dohme Corp. | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2011044184A1 (en) | 2009-10-08 | 2011-04-14 | Schering Corporation | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
WO2011115938A1 (en) | 2010-03-15 | 2011-09-22 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta - secretase modulators |
ES2450568T3 (es) | 2010-03-15 | 2014-03-25 | Amgen Inc. | Compuestos espiero de amino-dihidrooxazina y amino-dihidrotiazina como moduladores de beta-secretasa y su uso médico |
WO2012019056A1 (en) | 2010-08-05 | 2012-02-09 | Amgen Inc. | Amino-iso-indole, amino-aza-iso-indole, amino-dihydroisoquinoline and amino-benzoxazine compounds as beta-secretase modulators and methods of use |
US9284296B2 (en) | 2010-11-22 | 2016-03-15 | Aubergine Pharmaceuticals Llc | Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions |
US8957083B2 (en) | 2010-11-23 | 2015-02-17 | Amgen Inc. | Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use |
EP2673279A1 (en) | 2011-02-07 | 2013-12-18 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
WO2012112462A1 (en) | 2011-02-15 | 2012-08-23 | Amgen Inc. | Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use |
WO2012138734A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
US9181236B2 (en) | 2011-08-22 | 2015-11-10 | Merck Sharp & Dohme Corp. | 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use |
WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
DK2827711T3 (da) | 2012-03-19 | 2019-09-23 | Buck Inst Res Aging | App-specifikke bace-inhibitorer (asbi'er) og anvendelse deraf |
WO2014062549A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
US9416129B2 (en) | 2012-10-17 | 2016-08-16 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
WO2014127042A1 (en) | 2013-02-12 | 2014-08-21 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
CN114222573A (zh) * | 2019-08-16 | 2022-03-22 | 普度研究基金会 | 蛋白酶体核心颗粒的小分子刺激物 |
CN114702591B (zh) * | 2022-05-17 | 2022-09-23 | 诺赛联合(北京)生物医学科技有限公司 | 成体细胞衍生的类器官制备技术 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1168896B (de) * | 1962-06-16 | 1964-04-30 | Hoechst Ag | Verfahren zur Herstellung von N, N-disubstituierten Amidinen |
DE2235177A1 (de) * | 1972-07-18 | 1974-02-07 | Bayer Ag | Verfahren zur herstellung von lactamhydrazonen aromatischer systeme |
AU2003206588A1 (en) * | 2002-03-04 | 2003-09-16 | Procyon Biopharma Inc. | Urea derivatives as hiv aspartyl protease inhibitors |
US7592348B2 (en) * | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
PT1699455E (pt) * | 2003-12-15 | 2013-08-27 | Merck Sharp & Dohme | Inibidores de protease de aspartilo heterocíclicos |
JP2008503460A (ja) * | 2004-06-16 | 2008-02-07 | ワイス | β−セクレターゼのインヒビターとしてのジフェニルイミダゾピリミジンおよびイミダゾールアミン |
RU2006142552A (ru) * | 2004-06-16 | 2008-07-27 | Вайет (Us) | Производные амино-5,5-дифенилимидазолона как ингибиторы b-секретазы |
-
2006
- 2006-06-12 CN CNA2006800208944A patent/CN101193859A/zh active Pending
- 2006-06-12 WO PCT/US2006/022849 patent/WO2006138230A2/en active Application Filing
- 2006-06-12 JP JP2008516986A patent/JP2008543846A/ja active Pending
- 2006-06-12 US US11/451,194 patent/US20080113957A1/en not_active Abandoned
- 2006-06-12 AR ARP060102463A patent/AR054618A1/es not_active Application Discontinuation
- 2006-06-12 CA CA002610617A patent/CA2610617A1/en not_active Abandoned
- 2006-06-12 MX MX2007016186A patent/MX2007016186A/es unknown
- 2006-06-12 EP EP06772948A patent/EP1896406A2/en not_active Withdrawn
- 2006-06-13 PE PE2006000663A patent/PE20070073A1/es not_active Application Discontinuation
- 2006-06-13 TW TW095121030A patent/TW200716541A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006138230A3 (en) | 2007-04-12 |
JP2008543846A (ja) | 2008-12-04 |
TW200716541A (en) | 2007-05-01 |
CN101193859A (zh) | 2008-06-04 |
AR054618A1 (es) | 2007-07-04 |
CA2610617A1 (en) | 2006-12-28 |
US20080113957A1 (en) | 2008-05-15 |
WO2006138230A2 (en) | 2006-12-28 |
EP1896406A2 (en) | 2008-03-12 |
MX2007016186A (es) | 2008-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070073A1 (es) | Compuestos heterociclicos como inhibidores de proteasas | |
PE20070138A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasas | |
PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
PE20070531A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasas | |
PE20080072A1 (es) | Compuestos heterociclicos como inhibidores de proteasas serinas | |
PE20070321A1 (es) | Compuestos heterociclicos como inhibidores de proteasas | |
PH12014500760A1 (en) | Mesoionic pesticides | |
PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
PE20051048A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasa | |
PE20070367A1 (es) | Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa | |
NO20050741L (no) | Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den | |
PE20070135A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasas | |
PE20070136A1 (es) | COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1 | |
EA200701788A1 (ru) | Соединение 4-циклопропил-1,2,3-тиадиазола, агент для борьбы с болезнями растений для применения в сельском и садоводческом хозяйстве и метод его применения | |
PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
PE20070646A1 (es) | COMPUESTOS CON ESTRUCTURA DE CINAMIDA DE TIPO MORFOLINA COMO INHIBIDORES DE LA PRODUCCION DE ß-AMILOIDE | |
TW200510405A (en) | Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors | |
BRPI0511610A (pt) | derivados de amino-propanol | |
PE20061325A1 (es) | Derivados de pirrolidina como inhibidores de la renina | |
SG146658A1 (en) | Haloalkyl containing compounds as cysteine protease inhibitors | |
TW200716531A (en) | Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia | |
PE20091309A1 (es) | Derivados de ciclohexilo como inhibidores de acetil coenzima a carboxilasa | |
IN2012DN00785A (es) | ||
MX2009008925A (es) | Compuestos de la formula (i) como inhibidores de proteasa de serina. | |
CO5690637A2 (es) | Tiazol-(bi) cicloalquil-carboxanilidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |